Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

β1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts

Oncogene volume 18, pages 3852–3861 (1999)Cite this article

Abstract

To investigate the role of β1 integrin during tumor metastasis, we established a ras-myc transformed fibroblastoid cell line with a disrupted β1 integrin gene on both alleles (GERM 11). Stable transfection of this cell line with an expression vector encoding β1A integrin resulted in β1A integrin-expressing sublines. Tumors were induced by subcutaneous injection of GERM 11 cells and 3 independent β1 integrin expressing sublines (GERM 116, 1A10, 2F2) into syngeneic mice. After 10 days tumors were surgically removed. While average weights of GERM 11 and GERM 116 tumors were similar, tumors induced by the high expressing clones 1A10 and 2F2 were markedly smaller, suggesting an inverse correlation of tumor growth and β1 integrin expression. The metastasis potential of all three β1 integrin-expressing GERM 11 sublines tested was significantly higher than that of the β1-deficient GERM 11 cells. GERM 116 tumors led in all animals to severe metastasis in lung and liver, while GERM 11 tumors induced only a few metastatic foci in the lung. Stroma of both tumors contained nidogen and high amounts of tenascin C, but only a few very low levels of fibronectin, laminin-1, and collagen type I. β1 integrin, therefore, increases but is not essential for metastasis of ras-myc transformed fibroblasts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 3
Figure 1
Figure 2
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M and Buck CA. . 1990 Cancer Res. 50: 6757–6764.

  • Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW, Weidle UH, Addicks K and Fässler R. . 1997 J. Cell Biol. 139: 265–278.

  • Bottger BA, Hedin U, Johansson S and Thyberg J. . 1989 Differentiation 41: 158–167.

  • Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP and Cheresh DA. . 1996 Cell 85: 683–693.

  • Chan BM, Matsuura N, Takada Y, Zetter BR and Hemler ME. . 1991 Science 251: 1600–1602.

  • Coopman PJ, Thomas DM, Gehlsen KR and Mueller SC. . 1996 Mol. Biol. Cell 7: 1789–1804.

  • Coussens LM and Werb Z. . 1996 Chem. Biol. 3: 895–904.

  • Elliott BE, Ekblom P, Pross H, Niemann A and Rubin K. . 1994 Cell. Adhes. Commun. 1: 319–332.

  • Fässler R and Meyer M. . 1995 Genes Dev. 9: 1896–1908.

  • Fässler R, Pfaff M, Murphy J, Noegel AA, Johansson S, Timpl R and Albrecht R. . 1995 J. Cell Biol. 128: 979–988.

  • Fujita S, Watanabe M, Kubota T, Teramoto T and Kitajima M. . 1995 Cancer Lett. 91: 145–149.

  • Gehlsen KR, Argraves WS, Pierschbacher MD and Ruoslahti EJ. . 1988 Cell. Biol. 106: 925–930.

  • Giancotti FG and Ruoslahti E. . 1990 Cell 60: 849–859.

  • Gui GP, Puddefoot JR, Vinson GP, Wells CA and Carpenter R. . 1997 Br. J. Cancer 75: 623–633.

  • Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z and Damsky CH. . 1995 J. Cell Biol. 129: 867–879.

  • Humphries MJ, Yamada KM and Olden K. . 1988 J. Clin. Invest. 81: 782–790.

  • Hynes RO. . 1992 Cell 69: 11–25.

  • Kadler K. . 1994 Protein Profile 1: 519–638.

  • Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA and Virtanen I. . 1991 Hum. Pathol. 22: 636–643.

  • Larjava H, Lyons JG, Salo T, Makela M, Koivisto L, Birkedal-Hansen H, Akiyama SK, Yamada KM and Heino J. . 1993 J. Cell. Physiol. 157: 190–200.

  • Lessey BA, Albelda S, Buck CA, Castelbaum AJ, Yeh I, Kohler M and Berchuck A. . 1995 Am. J. Pathol. 146: 717–726.

  • Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K and Takada Y. . 1996 Am. J. Pathol. 148: 55–61.

  • Nakahara H, Nomizu M, Akiyama SK, Yamada Y, Yeh Y and Chen WT. . 1996 J. Biol. Chem. 27: 27221–27224.

  • Newton SA, Reeves EJ, Gralnick H, Mohla S, Yamada KM, Olden K and Akiyama SK. . 1995 Int. J. Oncol. 6: 1063–1070.

  • O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J. . 1994 Cell 79: 315–328.

  • Peters DMP and Mosher DF. . (1994). In: Extracellular matrix assembly and structure. Yurchenko PP, Birk DE and Mecham RP (eds). Academic Press: San Diego pp.315–350.

    Book  Google Scholar 

  • Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari VM and Heino J. . 1995 J. Biol. Chem. 270: 13548–13552.

  • Ruiz P, Dunon D, Sonnenberg A, Imhof BA. . 1993 Cell Adhes. Commun. 1: 67–81.

  • Ruoslahti E. . 1996 Ann. Rev. Cell. Dev. Biol. 12: 697–715.

  • Smilenov L, Forsberg E, Zeligman I, Sparrman M and Johansson S. . 1992 FEBs Lett. 18: 227–230.

  • Stetler-Stevenson WG, Aznavoorian S and Liotta LA. . 1993 Annu. Rev. Cell Biol. 9: 541–573.

  • Stroeken PJ, van Rijthoven EA, van der Valk MA, Roos E. . 1998 Cancer Res. 58: 1569–1577.

  • Thompson TC, Southgate J, Kitchener G and Land H. . 1989 Cell 56: 917–930.

  • Timpl R and Brown JC. . 1996 Bioessays 18: 123–132.

  • Wennerberg K, Lohikangas L, Gullberg D, Pfaff M, Johansson S and Fässler R. . 1996 J. Cell Biol. 132: 227–238.

  • Yamada KM, Kennedy DW, Yamada SS, Gralnick H, Chen WT and Akiyama SK. . 1990 Cancer Res. 50: 4485–4496.

  • Zutter MM, Santoro SA, Staatz WD and Tsung YL. . 1995 Proc. Natl. Acad. Sci. USA 92: 7411–7415.

Download references

Acknowledgements

We thank Stefan Benkert for his expert technical assistance, Dr Antonio Iglesias for the tail vein injection and Robert Anderson for critically reading the manuscript. This work was supported by the Swedish Cancerfonden (R Fässler) and by the Swedish Medical Research Council (S Johansson).

Author information

Authors and Affiliations

  1. Department of Experimental Pathology, Lund University Hospital, Lund, S-22185, Sweden

    Cord Brakebusch, Annahita Sallmyr & Reinhard Fässler

  2. Department of Medical Biochemistry and Microbiology, Biomedical Center, Box 575, Uppsala, S-75123, Sweden

    Krister Wennerberg & Staffan Johansson

  3. Boehringer Mannheim, 82372, Penzberg, Germany

    Hans W Krell & Ulrich H Weidle

Authors
  1. Cord Brakebusch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krister Wennerberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans W Krell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ulrich H Weidle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Annahita Sallmyr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Staffan Johansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Reinhard Fässler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brakebusch, C., Wennerberg, K., Krell, H. et al. β1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts. Oncogene 18, 3852–3861 (1999). https://doi.org/10.1038/sj.onc.1202770

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202770

Keywords

This article is cited by

Search

Advanced search

Quick links